← Leaderboards
Megan L Gasparovic
Brown University
$909,364
Attributed
$1,119,051
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $692.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,119,051 · 4
By mechanism
R01$502,248 · 1
R21$419,375 · 1
F31$113,090 · 1
F32$84,338 · 1
Top collaborators
- Steeve Boulant2 shared
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusCellsPathogenesisViral GenomeVirus DiseasesViralLife Cycle StagesProteinsPlayReceptor BindingPathway InteractionsPersonsPolyomavirusPropertyBinding (Molecular Function)Jc VirusMutantGenomeIntestinal EpitheliumIntestinesInfectionCell LineEpithelial CellsEnteral
Grant awards (8)
STING induced IFNL2/3 protects human intestinal epithelial cells from rotavirus infection$502,248
R01 · FY2025 · AI · contact PI
Using human intestinal organoids to evaluate JCV fecal/oral transmission$190,625
R21 · FY2025 · AI · contact PI
Using human intestinal organoids to evaluate JCV fecal/oral transmission$228,750
R21 · FY2024 · AI · contact PI
Mechanism of Class III viral fusion proteins.$38,748
F32 · FY2011 · AI · contact PI
Mechanism of Class III viral fusion proteins.$45,590
F32 · FY2010 · AI · contact PI
Role of JCV coat proteins in neuropathogenesis of PML$21,424
F31 · FY2007 · NS · contact PI
Role of JCV coat proteins in neuropathogenesis of PML$45,833
F31 · FY2006 · NS · contact PI
Role of JCV coat proteins in neuropathogenesis of PML$45,833
F31 · FY2005 · NS